An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two ...

An AI model from the Mayo Clinic can detect pancreatic cancer on routine scans up to 3 years before diagnosis, according to a ...

First clinical and immunogenicity results including all subjects enrolled in a phase I study of Nous-209, an off-the-shelf immunotherapy, with pembrolizumab, for the treatment of tumors with a ...

Artificial intelligence detected hidden signs of pancreatic cancer in normal scans long before a medical diagnosis was made.

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” Daraxonrasib, an ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. All your photos are now in play. Updated on Apr. 20 with additional analysis on Google’s new ...

When former Nebraska Sen. Ben Sasse was diagnosed with Stage 4 pancreatic cancer in December, he was given three to four months to live. Now a drug by Revolution Medicines is giving him precious more ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

Pancreatic cancer is one of the most challenging diseases to treat, and while survival rates have improved since the 1970s, they have plateaued in recent years. But two promising drugs in the pipeline ...

Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...

Pancreatic cancer is one of the deadliest cancers. It killed nearly 52,000 Americans last year, many within a year of diagnosis. Now, there are some new experimental medicines with the potential to ...

SAN DIEGO — Experimental therapies with radically different approaches are stirring a wave of optimism that survival rates could substantially improve for pancreatic cancer, one of the most stubbornly ...